Northern Trust’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-129,541
| Closed | -$81K | – | 4524 |
|
|
2020
Q4 | $81K | Sell |
129,541
-4,549
| -3% | -$2.81K | ﹤0.01% | 4158 |
|
|
2020
Q3 | $71K | Buy |
134,090
+13,986
| +12% | +$9.51K | ﹤0.01% | 4044 |
|
|
2020
Q2 | $83K | Buy |
120,104
+492
| +0.4% | +$390 | ﹤0.01% | 3961 |
|
|
2020
Q1 | $90K | Buy |
119,612
+19,767
| +20% | +$27.2K | ﹤0.01% | 3840 |
|
|
2019
Q4 | $151K | Sell |
99,845
-6,723
| -6% | -$10.1K | ﹤0.01% | 3859 |
|
|
2019
Q3 | $158K | Sell |
106,568
-388,914
| -78% | -$629K | ﹤0.01% | 3819 |
|
|
2019
Q2 | $640K | Sell |
495,482
-32,181
| -6% | -$59.2K | ﹤0.01% | 3490 |
|
|
2019
Q1 | $1.38M | Buy |
527,663
+13,045
| +3% | +$30.6K | ﹤0.01% | 3254 |
|
|
2018
Q4 | $849K | Buy |
514,618
+215,241
| +72% | +$604K | ﹤0.01% | 3413 |
|
|
2018
Q3 | $1.45M | Buy |
299,377
+4,699
| +2% | +$26.6K | ﹤0.01% | 3362 |
|
|
2018
Q2 | $1.84M | Buy |
294,678
+28,378
| +11% | +$212K | ﹤0.01% | 3241 |
|
|
2018
Q1 | $2.21M | Buy |
266,300
+3,616
| +1% | +$34.5K | ﹤0.01% | 3050 |
|
|
2017
Q4 | $2.68M | Buy |
262,684
+7,802
| +3% | +$74.9K | ﹤0.01% | 2974 |
|
|
2017
Q3 | $2.33M | Buy |
254,882
+53,616
| +27% | +$407K | ﹤0.01% | 3082 |
|
|
2017
Q2 | $1.47M | Buy |
201,266
+34,767
| +21% | +$262K | ﹤0.01% | 3324 |
|
|
2017
Q1 | $1.2M | Sell |
166,499
-313,615
| -65% | -$1.95M | ﹤0.01% | 3279 |
|
|
2016
Q4 | $2.81M | Buy |
480,114
+339,616
| +242% | +$2.3M | ﹤0.01% | 2902 |
|
|
2016
Q3 | $924K | Buy |
140,498
+4,687
| +3% | +$37.1K | ﹤0.01% | 3364 |
|
|
2016
Q2 | $1.26M | Buy |
135,811
+73,020
| +116% | +$697K | ﹤0.01% | 3272 |
|
|
2016
Q1 | $677K | Sell |
62,791
-200
| -0.3% | -$2.11K | ﹤0.01% | 3377 |
|
|
2015
Q4 | $902K | Buy |
62,991
+51,529
| +450% | +$777K | ﹤0.01% | 3356 |
|
|
2015
Q3 | $241K | Buy |
+11,462
| New | +$253K | ﹤0.01% | 3683 |
|
Northern Trust's NEOS Position: Q1 2021 in Review
Northern Trust sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 129,541 shares — an estimated $81K sold.
Northern Trust first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $2.81M in Q4 2016. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Northern Trust reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Northern Trust sold 129,541 Neos Therapeutics, Inc shares in Q1 2021, an estimated $81K.
- Northern Trust first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- Northern Trust's Neos Therapeutics, Inc position peaked at $2.81M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.